These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2844659

  • 1. Induction of simian virus 40 transplantation immunity in hamsters by gel-purified SV40 large T antigen.
    Haddada H, Le Goffic N, Chandrasekaran K, de Vaux Saint Cyr C.
    Immunol Lett; 1988 Jul; 18(3):225-9. PubMed ID: 2844659
    [Abstract] [Full Text] [Related]

  • 2. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW, Takemoto KK, Rogers MJ, Henriksen O, Ting RC.
    Int J Cancer; 1978 Sep 15; 22(3):315-22. PubMed ID: 212373
    [Abstract] [Full Text] [Related]

  • 3. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S, Huet C, Tournier P.
    Int J Cancer; 1977 Jul 15; 20(1):51-60. PubMed ID: 71274
    [Abstract] [Full Text] [Related]

  • 4. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS, Mylin LM, Fu TM, Tevethia SS.
    Virology; 1998 May 10; 244(2):427-41. PubMed ID: 9601511
    [Abstract] [Full Text] [Related]

  • 5. In vivo induction of tumor-specific immunity by glycolipid extracts of SV40-transformed cells.
    Ansel S, Blangy D.
    Int J Cancer; 1984 Oct 15; 34(4):555-9. PubMed ID: 6092285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
    Ansel S.
    Int J Cancer; 1983 Jun 15; 31(6):785-90. PubMed ID: 6190766
    [Abstract] [Full Text] [Related]

  • 12. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.
    Tan TH, Wallis J, Levine AJ.
    J Virol; 1986 Sep 15; 59(3):574-83. PubMed ID: 3016321
    [Abstract] [Full Text] [Related]

  • 13. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH, Bright RK, Kennedy RC.
    Cancer Res; 1993 Dec 01; 53(23):5734-9. PubMed ID: 7694794
    [Abstract] [Full Text] [Related]

  • 14. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK, Shearer MH, Kennedy RC.
    J Immunol; 1994 Sep 01; 153(5):2064-71. PubMed ID: 8051411
    [Abstract] [Full Text] [Related]

  • 15. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH, Bright RK, Lanford RE, Kennedy RC.
    Clin Exp Immunol; 1993 Feb 01; 91(2):266-71. PubMed ID: 7679059
    [Abstract] [Full Text] [Related]

  • 16. Detection of simian virus 40 T-antigen-related antigens by a 125I-protein A-binding assay and by immunofluorescence microscopy on the surface of SV40-transformed monolayer cells.
    Lange-Mutschler J, Deppert W, Hanke K, Henning R.
    J Gen Virol; 1981 Feb 01; 52(Pt 2):301-12. PubMed ID: 6270237
    [Abstract] [Full Text] [Related]

  • 17. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.
    Milner J, Cook A, Sheldon M.
    Oncogene; 1987 Feb 01; 1(4):453-5. PubMed ID: 3330789
    [Abstract] [Full Text] [Related]

  • 18. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
    Lowe DB, Shearer MH, Jumper CA, Bright RK, Kennedy RC.
    J Virol; 2010 Jan 01; 84(2):883-93. PubMed ID: 19889780
    [Abstract] [Full Text] [Related]

  • 19. Induction of tumors in Syrian hamsters by a human renal papovavirus, RF strain.
    Dougherty RM.
    J Natl Cancer Inst; 1976 Aug 01; 57(2):395-400. PubMed ID: 63561
    [Abstract] [Full Text] [Related]

  • 20. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis.
    Watts AM, Shearer MH, Pass HI, Bright RK, Kennedy RC.
    Cancer Immunol Immunother; 1999 Feb 01; 47(6):343-51. PubMed ID: 10203065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.